Hepatitis B Virus Reactivation under Treatment with Nilotinib

Hepatitis B virus (HBV) reactivation with imatinib, a tyrosine kinase inhibitor, has been reported in chronic myeloid leukemia. Nilotinib is a more potent second generation tyrosine kinase inhibitor and it inhibits the Src-family kinase LCK and hamper proliferation and function of CD8 (+) T lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Temel, Tuncer, Gunduz, Eren, Sadigova, Esmira, Uskudar Teke, Hava, Meric Ozgenel, Safak, Harmanci Ozakyol, Aysegul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578539/
https://www.ncbi.nlm.nih.gov/pubmed/29201705
http://dx.doi.org/10.5005/jp-journals-10018-1147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578539/
https://www.ncbi.nlm.nih.gov/pubmed/29201705
http://dx.doi.org/10.5005/jp-journals-10018-1147

Ejemplares similares